Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VALENROD, YEVGENY | 2 | 72.6% | +25.1% |
| HEITMEIER, KENDALL NICOLE | 1 | 63.9% | +41.7% |
| MOU, LIYUAN | 1 | 43.5% | +57.7% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +35.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17089448 | Diagnostic Method | FRITCHMAN, REBECCA M | 49d overdue |
| 18123143 | COMPOSITIONS COMPRISING UROLITHINS | HEITMEIER, KENDALL NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17089448 | Diagnostic Method | FRITCHMAN, REBECCA M | 49d overdue |
| 19170782 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | VALENROD, YEVGENY | 55d |
| 18205305 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | VALENROD, YEVGENY | — |
| 18123143 | COMPOSITIONS COMPRISING UROLITHINS | HEITMEIER, KENDALL NICOLE | — |
| 17284363 | COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENT | MOU, LIYUAN | — |
| Art Unit | Apps |
|---|---|
| 1628 | 3 |
| 1621 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19170782 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | VALENROD, YEVGENY | 1628 | §103 | Non-Final OA | 55d | Pending | Apr 04, 2025 |
| 18205305 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | VALENROD, YEVGENY | 1628 | §103 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18123143 | COMPOSITIONS COMPRISING UROLITHINS | HEITMEIER, KENDALL NICOLE | 1621 | §103§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 17284363 | COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENT | MOU, LIYUAN | 1628 | §103§112DPOther | Non-Final OA | — | Pending | Apr 09, 2021 |
| 17089448 | Diagnostic Method | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | 49d overdue | Pending | Nov 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial